Anni Winckelmann
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- HIV/AIDS drug development and treatment 7
- HIV/AIDS Research and Interventions 5
- SARS-CoV-2 and COVID-19 Research 4
- Virology 10
- HIV Research and Treatment 10
- Co-authors
- Sarah Palmer (5 shared papers)Lars Østergaard (9 shared papers)Ole S. Søgaard (9 shared papers)Martin Tolstrup (9 shared papers)Thomas A. Rasmussen (7 shared papers)Rikke Olesen (3 shared papers)Mathias Lichterfeld (3 shared papers)Sharon R. Lewin (2 shared papers)
- Journals
- AIDS (3 papers)EBioMedicine (2 papers)Viruses (2 papers)Frontiers in Microbiology (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- DenmarkUnited StatesAustralia
In The Last Decade
Anni Winckelmann
19 papers receiving 930 citations
Anni Winckelmann's Hit Papers
Peers
Comparison fields: 5 of 69
- Virology 718
- Infectious Diseases 544
- Immunology 310
- Emergency Medicine 65
- Epidemiology 154
Countries citing papers authored by Anni Winckelmann
This map shows the geographic impact of Anni Winckelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anni Winckelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anni Winckelmann more than expected).
Fields of papers citing papers by Anni Winckelmann
This network shows the impact of papers produced by Anni Winckelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anni Winckelmann. The network helps show where Anni Winckelmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Anni Winckelmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial Hit paper breakdown → | 2014 | 472 |
| 2 | 2016 | 94 | |
| 3 | 2019 | 71 | |
| 4 | 2016 | 60 | |
| 5 | 2013 | 44 | |
| 6 | 2013 | 39 | |
| 7 | 2015 | 28 | |
| 8 | 2017 | 28 | |
| 9 | 2021 | 26 | |
| 10 | 2021 | 16 | |
| 11 | 2022 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 2018 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 1987 | 6 | |
| 17 | 2021 | 2 | |
| 18 | 2017 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2025 | 0 |
About Anni Winckelmann
Anni Winckelmann is a scholar working on Infectious Diseases, Virology, Epidemiology, Immunology and Hepatology, having authored 20 papers that have together received 938 indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (7 papers), HIV/AIDS Research and Interventions (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Hepatitis B Virus Studies (4 papers), Immune Cell Function and Interaction (4 papers), Hepatitis C virus research (3 papers) and Cytomegalovirus and herpesvirus research (2 papers). The work is most often cited by research in Virology (718 citations), Infectious Diseases (544 citations), Immunology (310 citations), Emergency Medicine (65 citations) and Epidemiology (154 citations). Anni Winckelmann has collaborated with scholars based in Denmark, United States and Australia. Frequent co-authors include Sarah Palmer, Lars Østergaard, Ole S. Søgaard, Martin Tolstrup, Thomas A. Rasmussen, Rikke Olesen, Mathias Lichterfeld, Sharon R. Lewin, Ajantha Solomon and María J. Buzón. Their work appears in journals such as AIDS, EBioMedicine, Viruses, Frontiers in Microbiology and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.